Account
Inquiry
Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently being studied for type 2 diabetes treatment. Our high purity formulation demonstrates superior efficacy in glucose control and weight management compared to single receptor agonists.
This compound exhibits greater affinity for GIP receptors while maintaining significant GLP-1 receptor activity. The dual mechanism of action produces enhanced hyperglycemia reduction compared to selective GLP-1 receptor agonists. Research indicates tirzepatide effectively mimics natural GIP activity at receptor sites.
Our facility offers tirzepatide in various packaging configurations to meet diverse research requirements. The product undergoes rigorous quality control testing to ensure 99%+ purity and consistent batch-to-batch performance.
For researchers looking to buy tirzepatide online, we provide flexible customization options including different vial sizes (from 2mg to 50mg) and private labeling services. All products are strictly for research use only.
The compound shows promising results in metabolic studies, particularly for weight management applications. Third-party testing confirms our tirzepatide meets the highest purity standards for research purposes.
